• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: breast-cancer

  • Test Spares Extended Endocrine Therapy In Low-Risk ER+ Breast Cancer
    • in AJO · Audio · Oncology
    • — 18 Jul, 2018

    Test Spares Extended Endocrine Therapy In Low-Risk ER+ Breast Cancer

    CHICAGO—A gene test that predicts for relapse in women with estrogen receptor positive early breast cancer can identify patients with low-risk disease who could safely avoid extending their endocrine therapy beyond the standard five years, according to study findings reported …

    Read more
    Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer
    • in AJO · Audio · Oncology
    • — 18 Apr, 2018

    Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer

    BARCELONA—More pre-menopausal women who have estrogen receptor (ER) positive advanced breast cancer could be spared chemotherapy—according to latest findings from the MONALEESA-7 double-blind randomized phase 3 trial in which either placebo (PBO) or the cyclin-dependent kinase (CDK) 4/6 inhibitor ribociclib …

    Read more
  • Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation
    • in AJO · Audio · Oncology
    • — 17 Apr, 2018

    Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation

    BARCELONA—A multicenter nationwide Italian study of patients with ductal carcinoma in situ (DCIS) treated with breast conservative surgery (BCS) and whole breast radiotherapy (RT) has updated risk criteria to help women opt for gentler treatments and avoid toxicities from overtreatment.…

    Read more
    Double Mastectomy: No Survival Gain for BRCA2 Mutation Carriers—AUDIO JOURNAL OF ONCOLOGY
    • in AJO · Audio · Oncology
    • — 30 Mar, 2018

    Double Mastectomy: No Survival Gain for BRCA2 Mutation Carriers—AUDIO JOURNAL OF ONCOLOGY

    BARCELONA—Healthy women with BRCA1 mutations who opted for bilateral prophylactic mastectomy had their lives prolonged in comparison with similar women who did not. But in healthy women with the BRCA2 mutation the procedure did not improve overall survival even though …

    Read more
  • Big Fall in Malaria in The Gambia: Eradication in Sight? High Birth Weight Increases Breast Cancer Risk; Eat Fruit And Vegetables To Protect Your Vision!
    • in Public Health
    • — 7 Nov, 2008

    Big Fall in Malaria in The Gambia: Eradication in Sight? High Birth Weight Increases Breast Cancer Risk; Eat Fruit And Vegetables To Protect Your Vision!

    Brian Greenwood
    Brian Greenwood

    Brian Greenwood and David Conway tell Peter Goodwin how the incidence of malaria has fallen dramatically in The Gambia following the use of simple interventions such as insecticide-treated bed nets, and resistance-free drugs. The question now being asked
    …
    Read more
    New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
    • in Oncology
    • — 15 Dec, 2007

    New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

    Jose Baselga
    Jose Baselga

    JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
    RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and
    …
    Read more
  • AACR In New Partnership For San Antonio Breast Cancer Symposium
    • in News
    • — 14 Dec, 2007

    AACR In New Partnership For San Antonio Breast Cancer Symposium

    Margaret Foti
    Margaret Foti

    MARGARET FOTI, American Association for Cancer Research, Philadelphia
    The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer Therapy and Research Center at the University of Texas Health Science Center, Baylor College
    …
    Read more
    Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
    • in Oncology
    • — 14 Dec, 2007

    Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide

    Stephen Jones
    Stephen Jones

    STEPHEN JONES, US Oncology Research, Houston
    Long term data from an early breast cancer trial involving cyclophosphamide combined with docetaxel or doxorubicin have shown a survival advantage for the taxane. As Stephen Jones of US Oncology Research explained
    …
    Read more
  • Audio Journal of Oncology in Advance – March 1st, 2007
    • in ASCO · Oncology
    • — 2 Mar, 2007

    Audio Journal of Oncology in Advance – March 1st, 2007

    Lorie Hughes
    Lorie Hughes
    Rachel Ellsworth
    Rachel Ellsworth
    Rowan Chlebowski
    Rowan Chlebowski
    Victor Vogel
    Victor Vogel

    Local Excision Alone for Selected Patients with Ductal Carcinoma In Situ?

    REFERENCE: Abstract: 29
    LORIE HUGHES, The Hope Center, Cartersville GA
    The intergroup study E-5194 has found that local excision without radiation

    …
    Read more
    Audio Journal of Medicine – July 20th
    • in General Medicine
    • — 20 Jul, 2006

    Audio Journal of Medicine – July 20th

    Jean Scott and Peter Illingworth
    Jean Scott and Peter Illingworth
    Richard Anderson
    Richard Anderson
    Anna Pia Ferraretti
    Anna Pia Ferraretti

    More Boys from IVF compared to ICSI

    REFERENCE: Abstract O-41
    Jean Scott, IVF Australia, Hunters Hill, New South Wales; Peter Illingworth, Medical Director of IVF Australia
    In vitro fertilisation results
    …
    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: breast-cancer

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.